Medivand: Request for a clinical trial for a new product – the capital market
The Israeli Biotechnology Company Medivand + 15.54% closure:0 opening:0 High:0 low:0 cycle:- Page Quote News Graphs Company Profile Recommendations More articles on the subject: Traded on the NASDA…
